Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Cinnamon vs Omega-3: Omega-3 has the stronger overall evidence (9 vs 6.8/10); they're alternatives for inflammation-related symptoms — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Omega-3 wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
1 of 1 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
10 of 15 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (2)
Outcomes where both Cinnamon and Omega-3 have evidence — compare verdict strength side-by-side.
1,000 mg (1 g) cinnamon powder daily, or 250-500 mg standardized extract. Prefer Ceylon for regular use. The cited type 2 diabetes trial used 500 mg bark powder capsules, two a day. Label products go up to 6 g of powder a day, a figure from the ranges of the cited meta-analyses but not the dose of any cited trial. A cited dose-response meta-analysis found fat mass fell only at 2 g a day or more taken for at least 12 weeks.
With meals
Ceylon cinnamon powder or standardized aqueous extract
2-3g combined EPA+DHA daily (a typical label dose, not the dose used in the cited trials, which gave 1 g or 3.25 g of omega-3 a day, or 1 to 4 g of fish oil a day without stating its EPA+DHA content)
With meals containing fat
Triglyceride form fish oil
4-12 weeks
4-12 weeks
8-12 weeks
8-12 weeks
4-8 weeks
2-4 weeks
Immediate
4-12 weeks
The effect of cinnamon supplementation on glycemic control in patients with type 2 diabetes mellitus: An updated systematic review and dose-response meta-analysis of randomized controlled trials
Phytotherapy research : PTR (2024) · Meta analysis
Significant reduction in fasting blood sugar (SMD −1.32; 95% CI −1.77 to −0.87; p<0.001)
Effects of cinnamon supplementation on metabolic biomarkers in individuals with type 2 diabetes
Nutrition reviews (2025) · Meta analysis · n=3054
Improvements in glycemic and lipid biomarkers reported
Efficacy and safety of cinnamon in type 2 diabetes mellitus and pre-diabetes patients: A meta-analysis and meta-regression
Diabetes research and clinical practice (2019) · Meta analysis
Significant reduction in fasting blood glucose
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
The New England journal of medicine (2019) · Rct · n=25871
During a median follow-up of 5.3 years, a major cardiovascular event occurred in 386 participants in the n-3 group and in 419 in the placebo group (hazard ratio, 0.92; 95% confidence interval [CI], 0.80 to 1.06; P=0.24).
Omega-3 fatty acids for intermittent claudication
The Cochrane database of systematic reviews (2024) · Meta analysis · n=1830
Omega-3 compared with a control may have little to no effect on ankle-brachial index (MD -0.02, 95% CI -0.08 to 0.04; 3 studies, 168 participants; very low-certainty evidence).
A systematic review and meta-analysis of the omega-3 fatty acids effects on brain-derived neurotrophic factor (BDNF)
Nutritional neuroscience (2024) · Meta analysis · n=587
12 RCTs with 587 subjects: omega-3 supplementation increased serum BDNF versus placebo (SMD 0.72, 95% CI 0.28 to 1.15), with high heterogeneity (I2 = 84.39%).
The points are the dose bands of a meta-analysis of 10 randomised trials with 1,426 adults (PMID 37028202): EPA-rich products at 1 to under 2 g of EPA a day reduced depression severity (SMD -0.43), while 2 g a day or more did not (SMD -0.20, not significant), so the 2 g point is plotted as no effect. Doses are grams of EPA, not EPA plus DHA. The Cochrane review of 33 placebo-controlled trials found a small to modest effect, unlikely to be clinically meaningful and rated very low certainty, with no difference in remission or response (PMID 34817851). No trial compared doses directly.
AI-estimated from published studies. Interpret as directional guidance.
Omega-3 has a higher evidence score (9/10 vs 6.8/10) and wins in 3 of 3 categories.
For inflammation-related symptoms, Omega-3 has a higher relevance score (85 vs 40).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
Berberine, inositol, magnesium vs the cinnamon/chromium hype — and the med-interaction warning.
The honest tier list — proven staples vs situational vs mostly marketing. The hub the other guides feed into.
On Ozempic/Wegovy/Mounjaro? What actually helps — muscle preservation, GI relief, nutrient gaps (no upsell).
Which supplements clash with blood thinners, thyroid meds, antibiotics & more — and what to do.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.